NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

4 - Travere Therapeutics, Inc.

Filed: 2026-04-16 AccNo: 0001123343-26-000002 Size: 9 KB
查看原文来源主页查看事件簇按来源查看
发布时间04/16 20:05 UTC
首次发现04/16 20:07 UTC
热度106.3
重要度74
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 426 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001123343-26-000002

Filing Date: 2026-04-16

Accepted: 2026-04-16 16:05:17

Documents: 1

Period of Report: 2026-04-14

LYONS GARY A ( Reporting ) CIK : 0001123343 (see all company filings) State of Incorp.: DE | Fiscal Year End: 1231 Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 26867530

1 | form4-04162026_040407.xml | 4 | 7345

同簇相关文章

从当前文章回到同一事件簇里的其他来源或补充材料。
5 篇